Ioannis Katsoulis has joined CF as director of Life Sciences bringing over 12 years of experience in global market access, pricing, and health policy research, with a strong track record of delivering strategic insights across top pharmaceutical and biotech companies. Ioannis partnered with cross-functional teams throughout his career to optimise the value proposition of therapies by demonstration of benefits for patients and healthcare systems.
Most recently, Ioannis served as Associate Principal at IQVIA, leading value communications and pricing engagements across therapy areas. Prior to IQVIA, he held roles of increasing responsibility at different consultancies including Evidera and ICON, where he engaged in health technology assessment (HTA), market access and pricing for medicines across their lifecycle. His work has informed evidence generation plans, global value dossiers, launch readiness, and global market access and pricing strategy.
Ioannis’s expertise spans evidence generation planning and synthesis, real-world evidence studies, and strategic payer and physician key opinion leader engagements across major global markets, with a focus on the EU4 markets, the UK, US, China and Japan. His published work covers a broad range of topics on the use of real-world data for HTA and payer decision-making, with a focus in oncology and autoimmune conditions, reflecting a commitment to advancing evidence-based policy and strategic market access for innovative therapies.
Hannah Farrar, CEO of CF, said: “Ioannis’s appointment underscores our commitment to deepening our life sciences expertise and expanding our market access capabilities. His extensive experience in leveraging real-world evidence to inform healthcare decision-making aligns perfectly with our mission to drive meaningful impact across the healthcare sector. We’re building a team that can deliver transformative outcomes for our clients, and Ioannis will make a great addition to that vision.”
Ben Richardson, Managing Partner of Life Sciences for CF, commented, “I am delighted that Ioannis has joined CF as a director. His experience as a strategic advisor to global pharmaceutical and biotech companies, combined with his expertise in real-world evidence and health technology assessment, will significantly strengthen our ability to leverage our unrivalled access to health data in the UK making it relevant for life sciences companies in the UK and across Europe. Ioannis will support CF’s aim of driving the adoption of innovation to improve health and healthcare. “
Ioannis has a strong background in the market access field, and brings a proven ability to translate complex evidence into actionable strategies that drive meaningful outcomes for patients and healthcare systems. His appointment reflects our commitment to bringing world-class talent to CF as we continue to expand our life sciences capabilities.
Ioannis Katsoulis
Commenting on his appointment, Ioannis, “I am energised to join CF and help expand its market access capabilities by integrating real-world data into strategic access and evidence planning. Looking forward to partnering with clients to deliver impactful, data-driven solutions that accelerate access and improve patient outcomes.”
CF is a leading consultancy with a purpose to make an enduring impact on health and healthcare. We work with leaders and frontline teams to improve health, transform healthcare, drive adoption of innovation and create value through investment.
Our mission is to be invaluable to our clients, supporting them to innovate and make lasting improvements and to build an exceptional company that attracts, develops, and retains a trusted and uniquely talented team.
Our consultancy serves the entire healthcare sector, from payors and providers of care, to life science companies, health tech and sector suppliers and health investors. We provide end-to-end services, from strategy through implementation, accelerated by data, digital and AI . We shape opinion through evidence-based thought leadership on key issues affecting health. With unmatched ability to access to health data, our consultants are a driving force for delivering positive and meaningful change.
CF headquarters are in London with Middle East headquarters in Riyadh and an office in Dubai. It serves clients in the UK and across Europe and the Middle East.
